The Appropriate Elicitation of Expert Opinion in Economic Models William SullivanKatherine Payne Commentary 11 December 2012 Pages: 455 - 459
Pharmacoeconomic Considerations in Treating Iron Overload in Patients with β-Thalassaemia, Sickle Cell Disease and Myelodysplastic Syndromes in the US Bin ZhangPrina Z. DongaChris L. Pashos Review Article 11 December 2012 Pages: 461 - 474
Health Technology Funding Decision-Making Processes Around the World Tania StafinskiDevidas MenonChristopher McCabe Review Article 11 December 2012 Pages: 475 - 495
A Discrete-Event Simulation of Smoking-Cessation Strategies Based on Varenicline Pivotal Trial Data James G. XenakisElizabeth T. KinterJ. Jaime Caro Original Research Article 11 December 2012 Pages: 497 - 510
The Direct Medical Costs Associated with Suspected Heparin-Induced Thrombocytopenia Natasha NanwaNicole MittmannWilliam Geerts Original Research Article 11 December 2012 Pages: 511 - 520
A Value Set for the EQ-5D Based on Experienced Health States Reiner LeidlPeter Reitmeir Original Research Article 11 December 2012 Pages: 521 - 534
Intravenous Esomeprazole Gillian M. Keating Adis Pharmacoeconomic Drug Profile 11 December 2012 Pages: 535 - 543